<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    IVERIC bio, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About IVERIC bio, Inc.

    IVERIC bio is a gene therapy focused company developing innovative treatments for patients with orphan inherited retinal diseases with significant unmet medical needs. We have a diversified and scientifically compelling pipeline of product candidates. At IVERIC bio we understand the critical importance of vision in the quality of life of patients. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $600,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Glenn P. Sblendorio
    • FOUNDED
      2007
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Integra LifeSciences Holdings Corporation

    Integra LifeSciences Holdings Corporation

    Integra LifeSciences, a world leader in medical devices, is dedicated to limiting ...

    Integra LifeSciences, a world leader in medical...

    Filing Type:    PU
    Stealth BioTherapeutics Corp.

    Stealth BioTherapeutics Corp.

    We are an innovative biopharmaceutical company developing therapies to treat the m...

    We are an innovative biopharmaceutical company ...

    Filing Type:    PU
    Cerus Corporation

    Cerus Corporation

    Cerus Corporation is dedicated solely to safeguarding the world’s blood supply a...

    Cerus Corporation is dedicated solely to safegu...

    Filing Type:    PU
    TG Therapeutics, Inc.

    TG Therapeutics, Inc.

    TG Therapeutics is a biopharmaceutical company focused on the acquisition, develop...

    TG Therapeutics is a biopharmaceutical company ...

    Filing Type:    PU
    Lexicon Pharmaceuticals, Inc.

    Lexicon Pharmaceuticals, Inc.

    Lexicon Pharmaceuticals is a fully integrated biopharmaceutical company that is ap...

    Lexicon Pharmaceuticals is a fully integrated b...

    Filing Type:    PU
    Arbutus Biopharma Corporation

    Arbutus Biopharma Corporation

    Arbutus Biopharma is a publicly-traded (NASDAQ:ABUS) biopharmaceutical company ded...

    Arbutus Biopharma is a publicly-traded (NASDAQ:...

    Filing Type:    PU
    Fibrocell Science Inc.

    Fibrocell Science Inc.

    Fibrocell is a cell and gene therapy company focused on improving the lives of peo...

    Fibrocell is a cell and gene therapy company fo...

    Filing Type:    PU
    Audentes Therapeutics, Inc.

    Audentes Therapeutics, Inc.

    Audentes Therapeutics is a leading AAV-based genetic medicines company focused on ...

    Audentes Therapeutics is a leading AAV-based ge...

    Filing Type:    PU
    uniQure N.V.

    uniQure N.V.

    uniQure is delivering on the promise of gene therapy -- single treatments with pot...

    uniQure is delivering on the promise of gene th...

    Filing Type:    PU
    Ocugen, Inc.

    Ocugen, Inc.

    Ocugen is a clinical stage biopharmaceutical company focused on discovering, devel...

    Ocugen is a clinical stage biopharmaceutical co...

    Filing Type:    PU
    Outlook Therapeutics, Inc.

    Outlook Therapeutics, Inc.

    Outlook Therapeutics is a late clinical-stage biopharmaceutical company focused on...

    Outlook Therapeutics is a late clinical-stage b...

    Filing Type:    PU
    Kala Pharmaceuticals, Inc.

    Kala Pharmaceuticals, Inc.

    Kala Pharmaceuticals, Inc. (Kala) is a biopharmaceutical company focused on the de...

    Kala Pharmaceuticals, Inc. (Kala) is a biopharm...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.